Literature DB >> 2246251

Characterization of caldesmon binding to myosin.

M E Hemric1, J M Chalovich.   

Abstract

Caldesmon inhibits the binding of skeletal muscle subfragment-1 (S-1).ATP to actin but enhances the binding of smooth muscle heavy meromyosin (HMM).ATP to actin. This effect results from the direct binding of caldesmon to myosin in the order of affinity: smooth muscle HMM greater than skeletal muscle HMM greater than smooth muscle S-1 greater than skeletal muscle S-1 (Hemric, M. E., and Chalovich, J. M. (1988) J. Biol. Chem. 263, 1878-1885). We now show that the difference between skeletal muscle HMM and S-1 is due to the presence of the S-2 region in HMM and is unrelated to light chain composition or to two-headed versus single-headed binding. Differences between the binding of smooth and skeletal muscle myosin subfragments to actin do not result from the lack of light chain 2 in skeletal muscle S-1. In the presence of ATP, caldesmon binds to smooth muscle myosin filaments with a stoichiometry of 1:1 (K = 1 x 10(6) M-1). Similar results were obtained for the binding of caldesmon to smooth muscle rod as well as the binding of the purified myosin-binding fragment of caldesmon to smooth muscle myosin. The binding of caldesmon to intact myosin is ATP sensitive. The interaction of caldesmon with myosin is apparently specific and sensitive to the structure of both proteins.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2246251      PMCID: PMC1201128     

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  Separation of subfragment-1 isoenzymes from rabbit skeletal muscle myosin.

Authors:  A G Weeds; R S Taylor
Journal:  Nature       Date:  1975-09-04       Impact factor: 49.962

2.  Characteristics of the myosin and tropomyosin binding regions of the smooth muscle caldesmon.

Authors:  E Katayama; K Y Horiuchi; S Chacko
Journal:  Biochem Biophys Res Commun       Date:  1989-05-15       Impact factor: 3.575

3.  Phosphorylation of caldesmon prevents its interaction with smooth muscle myosin.

Authors:  C Sutherland; M P Walsh
Journal:  J Biol Chem       Date:  1989-01-05       Impact factor: 5.157

4.  Dissociation of the effect of caldesmon on the ATPase activity and on the binding of smooth heavy meromyosin to actin by partial digestion of caldesmon.

Authors:  L Velaz; R H Ingraham; J M Chalovich
Journal:  J Biol Chem       Date:  1990-02-15       Impact factor: 5.157

5.  Ca2+ regulation of the thin filaments: biochemical mechanism and physiological role.

Authors:  S Marston; K Pritchard; C Redwood; M Taggart
Journal:  Biochem Soc Trans       Date:  1988-08       Impact factor: 5.407

6.  Caldesmon inhibits the cooperative turning-on of the smooth muscle heavy meromyosin by tropomyosin-actin.

Authors:  K Y Horiuchi; S Chacko
Journal:  Biochemistry       Date:  1989-11-14       Impact factor: 3.162

7.  Cloning and expression of a smooth muscle caldesmon.

Authors:  J Bryan; M Imai; R Lee; P Moore; R G Cook; W G Lin
Journal:  J Biol Chem       Date:  1989-08-15       Impact factor: 5.157

8.  Complete primary structure of vertebrate smooth muscle myosin heavy chain deduced from its complementary DNA sequence. Implications on topography and function of myosin.

Authors:  M Yanagisawa; Y Hamada; Y Katsuragawa; M Imamura; T Mikawa; T Masaki
Journal:  J Mol Biol       Date:  1987-11-20       Impact factor: 5.469

9.  Binding of caldesmon to smooth muscle myosin.

Authors:  M Ikebe; S Reardon
Journal:  J Biol Chem       Date:  1988-03-05       Impact factor: 5.157

10.  The binding of caldesmon to actin and its effect on the ATPase activity of soluble myosin subfragments in the presence and absence of tropomyosin.

Authors:  L Velaz; M E Hemric; C E Benson; J M Chalovich
Journal:  J Biol Chem       Date:  1989-06-05       Impact factor: 5.157

View more
  33 in total

1.  Sarcomeric binding pattern of exogenously added intact caldesmon and its C-terminal 20-kDa fragment in skinned fibers of skeletal muscle.

Authors:  S M Frisbie; M C Reedy; L C Yu; B Brenner; J M Chalovich; T Kraft
Journal:  J Muscle Res Cell Motil       Date:  1999-04       Impact factor: 2.698

2.  A mosaic multiple-binding model for the binding of caldesmon and myosin subfragment-1 to actin.

Authors:  Y D Chen; J M Chalovich
Journal:  Biophys J       Date:  1992-10       Impact factor: 4.033

3.  Involvement of caldesmon at the actin-myosin interface.

Authors:  M C Harricane; E Fabbrizio; C Arpin; D Mornet
Journal:  Biochem J       Date:  1992-10-15       Impact factor: 3.857

Review 4.  Calponin (CaP) as a latch-bridge protein--a new concept in regulation of contractility in smooth muscles.

Authors:  Pawel T Szymanski
Journal:  J Muscle Res Cell Motil       Date:  2004       Impact factor: 2.698

5.  Functional interrelationship between calponin and caldesmon.

Authors:  R Makuch; K Birukov; V Shirinsky; R Dabrowska
Journal:  Biochem J       Date:  1991-11-15       Impact factor: 3.857

6.  A long helix from the central region of smooth muscle caldesmon.

Authors:  C L Wang; J M Chalovich; P Graceffa; R C Lu; K Mabuchi; W F Stafford
Journal:  J Biol Chem       Date:  1991-07-25       Impact factor: 5.157

Review 7.  The molecular anatomy of caldesmon.

Authors:  S B Marston; C S Redwood
Journal:  Biochem J       Date:  1991-10-01       Impact factor: 3.857

8.  Immunocytochemical localization of caldesmon and calponin in chicken gizzard smooth muscle.

Authors:  K Mabuchi; Y Li; T Tao; C L Wang
Journal:  J Muscle Res Cell Motil       Date:  1996-04       Impact factor: 2.698

9.  Mode of caldesmon binding to smooth muscle thin filament: possible projection of the amino-terminal of caldesmon from native thin filament.

Authors:  E Katayama; M Ikebe
Journal:  Biophys J       Date:  1995-06       Impact factor: 4.033

10.  Reversal of caldesmon binding to myosin with calcium-calmodulin or by phosphorylating caldesmon.

Authors:  M E Hemric; F W Lu; R Shrager; J Carey; J M Chalovich
Journal:  J Biol Chem       Date:  1993-07-15       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.